Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Diffuse Intrinsic Pontine Glioma × Temozolomide × Clear all

Phase

Status

Completed 4 Terminated 3 Recruiting 3 Unknown 2 Active not recruiting 2 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 11 Glioma 4 Medulloblastoma 2 Triple Negative Breast Neoplasms 1 Solid Tumor Cancer 1 Sarcoma, Ewing 1 SCLC, Extensive Stage 1 Recurrence 1 Primary Glioblastoma 1 Lymphoma, Follicular 1 Hypoxia 1 Ependymoma 1 Diffuse Intrinsic Pontine Glioma 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

tovorafenib 1 gallium maltolate 1 Temozolomide 1 Re-Irradiation 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06639607 2026-03-10

PRiME II

Washington University School of Medicine

Phase 1/2 Not yet recruiting

Diffuse Intrinsic Pontine Glioma, Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡